Your DRG program is working. Your CDI team is improving documentation. Your denial rates look manageable. So why are revenue cycle leaders at health systems across the country still leaving millions on the table every year?
The answer is hiding in a window most RCM programs were never built to cover: the post-bill window, where two distinct revenue problems live side by side, and where payers are getting very good at winning quietly.
Over the past several years, the healthcare revenue cycle industry has made a significant move upstream. CDI tools, pre-bill DRG validation, concurrent review — the investment has followed the belief that if you get the claim right before it leaves, the back end takes care of itself.
Payers did not get that memo.
While hospitals and vendors invested in the front end, payers deployed AI and automated audit tools on the back end, reviewing clinical documentation after care was already delivered and payment was already made. The result is a post-bill environment that is more aggressive, more automated, and more difficult to detect than anything that came before it.
DRG downgrades increased nearly 57% between 2022 and 2023. They are now one of the fastest-growing payer denial tactics in the industry. And most of them never show up as denials at all.
A silent denial does not arrive as a rejection. It arrives as a quiet payment adjustment on the 835 file with no denial code, no workflow trigger, and no alert to your team. The account shows paid. The revenue is reduced. And your dashboard still shows green.
By the time a pattern surfaces in your denial reporting, the damage has already compounded. Repeated DRG downgrades do not just reduce individual claim payments. They quietly erode your Case Mix Index, anchoring your prospective payment rates to understated clinical complexity for years.
This is the first of two problems in the post-bill window. The second is less visible still.
DRG Validation addresses a different problem entirely. In paid claims that have already closed, a blank-slate clinical review often finds diagnoses the documentation supports but the original billing process could not see. Missed CC and MCC conditions. Under-captured clinical complexity. Revenue your hospital earned, billed for at a lower level than the chart justifies, and collected without ever knowing the difference.
Industry data suggests that a significant share of inpatient paid claims carry a lower DRG weight than the documentation can actually support. U.S. hospitals spent $18 billion overturning denials in 2025 alone. The revenue quietly under-captured in paid claims may be just as significant.
Most hospitals have something in place for DRG oversight. The challenge is that existing programs rarely address both sides of the post-bill picture, and the resource math makes it daunting to go after either problem systematically with internal staff alone.
The organizations recovering the most DRG revenue in 2026 share a few characteristics. They have a workflow specifically designed for the post-bill window, not just pre-bill validation. They track silent denial patterns by payer and by DRG cluster, not just overall denial rates. And they close the loop, feeding what they learn in post-bill reviews back to CDI teams and physicians in a format that actually changes documentation behavior.
Perhaps most importantly, they address both problems together. The intelligence from DRG Validation work sharpens where to look for Downcode Defense patterns, and vice versa. Running both programs simultaneously produces better results than either alone.
On June 17 at 12:00 PM ET, EnableComp is hosting a free educational webinar, The Pre-Bill Blind Spot, where our clinical and revenue cycle experts will break down exactly how both problems work, which DRG clusters are most at risk right now, and what an integrated post-bill DRG strategy looks like in practice.
This is a moderated expert conversation, not a product pitch. Designed for VP Revenue Cycle, CFO, and CDI Director audiences who want specific, actionable intelligence they can bring back to their teams.
Can't attend live? Register anyway. The replay will be available to all registrants.
Register for The Pre-Bill Blind Spot Webinar
EnableComp specializes in post-bill DRG Validation and Downcode Defense for health systems across the country. To learn more, visit enablecomp.com.